IMAGE

Fig. 2

ID
ZDB-IMAGE-231113-12
Source
Figures for Stevick et al., 2023
Image
Figure Caption

Fig. 2

Loperamide affects conventional zebrafish microbiota as measured by 16S rRNA gene amplicons. A NMDS plot calculated using Bray–Curtis beta-diversity (k = 2) of percent normalized ASVs from 16S rRNA gene amplicons. Ellipse lines show the 95% confidence interval (standard deviation). Stress = 0.136; adonis2 PERMANOVA R2 = 0.104; p = 0.029*. Only DMSO and loperamide-treated samples are shown. B Significant differentially abundant genera in loperamide-treated fish, compared to DMSO controls at each timepoint calculated using Limma (one against one) with conditions: relative log expression (RLE) normalized, effect log fold change > 2, Benjamini and Hochberg adjusted p-value < 0.05 (n = 5 per condition). Genera that occur at mean percent abundance > 1% are outlined in black and bold. C Beta-dispersion or within-condition dissimilarity index calculated using Bray–Curtis beta-diversity (n = 20). ****p < 0.001 for loperamide treatment, compared to DMSO. Wilcoxon test

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Microbiome